Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PathoGenetix, formerly called US Genomics, announced today the first closing of its Series B financing round, raising $4 million.

The Woburn, Mass.-based company added that it has received $9.5 million in commitments from investors for the round.

The funds will be used to complete development of PathoGenetix's first commercial systems for identifying pathogens in complex biological samples using its Genome Sequence Scanning technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.